Please login to the form below
privacy
This page shows the latest privacy news and features for those working in and with pharma, biotech and healthcare.
Almirall set to participate in Innovative Medicines Initiative’s FACILITATE project
The company aims to offer its expertise in privacy and pharmaceutical law issues, while developing guidance, standards and recommendations for the safe return of clinical trial data to patients.
Latest news
-
First evidence-based guide launched to put patients at heart of digital innovations
as data privacy, intellectual property, inclusivity, reimbursement, usability and recruitment of patients for health technology entrepreneurs.
-
UK government announce £260m to boost healthcare research and manufacturing
This will make vital data more secure, easily available for research and offered with high levels of privacy.
-
Making social sexy
Only social media can provide the reach and privacy to make that a reality.
-
Vaccine developers call on FDA to offer clarity on COVID-19 trials
We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,”
-
J&J halts COVID-19 vaccine study after unexplained participant illness
We must respect this participant’s privacy. We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,”
More from news
Approximately 0 fully matching, plus 101 partially matching documents found.
Latest Intelligence
-
Focusing in on real-world evidence and its capabilities
Several barriers to the use of RWE in the EU require close consideration, including concerns with regard to data privacy and access issues, as well as to relevance, fragmentation, depth and
-
Harnessing the power of AI in clinical trials
We must ensure we are prioritising ethical principles. Issues such as the right to privacy should be taken seriously in the design of AI models and be front of mind throughout
-
The five ‘innovation areas’ driving success in chronic diseases
As well as the well-publicised privacy issues, the creators never fundamentally defined the problem that the product was solving for its potential users.
-
Mind the gap: are digital health solutions really patient centric?
They felt less comfortable discussing their condition in the locations they were dialling in from because of a lack of privacy.
-
Merging global and local pharmacovigilance operations into a successful integrated approach
There are significant time, costs, privacy regulations and language requirements that must be considered.
More from intelligence
Approximately 2 fully matching, plus 51 partially matching documents found.
Latest appointments
-
Signant Health appoints new chief compliance and security officer
He has 30 years of experience in security, quality management and data privacy, with 20 of those years in senior life sciences roles. ... Our clients increasingly view data security and privacy as a critical part of their overall quality strategy.
-
Alexion Pharmaceuticals adds to its board
She brings strong corporate governance and legal expertise, with a proven track records in global compliance, strategic planning, data privacy and regulatory matters.
-
23andMe names privacy officer and corporate counsel
Personal genetics firm 23andMe has appointed Kate Black as privacy officer and corporate counsel. ... privacy and consent policies best complement our philosophy on the importance of customer choice and empowerment.
-
Covington boosts European life sciences group
Koyuncu has also worked in compliance, privacy and product liability matters, along with assisting life sciences clients with corporate transactions.
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
Could femtech be the answer to the gender health gap?
Privacy. While the vast amount of data collected through these apps and products has the potential to narrow the gender health gap, it is critical that the uses of this data ... Published February 3, 2021. Accessed November 4, 2021. Lomas N. Flo gets FTC
-
Ten ways to start (or continue) your patient engagement journey
patients and/or use blinded question types to reinforce privacy and compliance. [
-
The ongoing evolution of Medical Affairs
Further, Eddie gives his thoughts on the role of technology in applying systems thinking, including barriers such as concerns about data privacy and bioethics.
-
Report: Omnichannel advice for the life science industry
Drive personalization in a world of stricter privacy laws. Empower medical affairs and marketing teams to develop sustainable experiences.
-
What does the future hold for clinical trial recruitment?
But more recently – driven by Facebook’s data privacy issues – social media platforms have added restrictions to targeting people based on key criteria and their recruitment role has been less effective. ... Worries over data privacy also
More from PMHub
Approximately 15 fully matching, plus 35 partially matching documents found.
Subscribe to our email news alerts
- HCP ENGAGEMENT STUDY: Pharma shifts top priority to HCP insights and impact metrics
- AstraZeneca/Merck’s Lynparza combination recommended by NICE for advanced ovarian cancer
- BMS shares positive phase 3 results for Opdivo/Yervoy combination in colorectal cancer
- Stanford Medicine researchers find blood tests help predict organ failure
- GSK and GCOA report reveals global inequities in adult immunisation uptake
- A “Leaky Pipeline” and the Loss of Talented Female Physicians
No results were found
PMHub
An agency called Owen
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....
Latest intelligence
- Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
- ...
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
